Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-26.5%
5Y CAGR-14.5%
Year-over-Year Change
Research and development spending
3Y CAGR
-26.5%/yr
vs +16.7%/yr prior
5Y CAGR
-14.5%/yr
Recent deceleration
Acceleration
-43.2pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $43.44M | +2.9% |
| 2022 | $42.20M | -51.7% |
| 2021 | $87.30M | -20.2% |
| 2020 | $109.38M | +37.9% |
| 2019 | $79.33M | -16.5% |
| 2018 | $94.96M | +44.1% |
| 2017 | $65.89M | +11.8% |
| 2016 | $58.94M | +16.1% |
| 2015 | $50.77M | -27.1% |
| 2014 | $69.66M | - |